Vifor Pharma UK Limited

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2026	1	Value not published	1
2025	1	Value not published	1
2024	1	Value not published	1
2023	1	Value not published	1
2018	2	Value not published	2
2017	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierVifor Pharma UK Limited

Source records

Published awards

13 records linked to this supplier.

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Buyer: NHS England
End date in notice
31 Aug 2028Date from the linked contract
Value shown in notice
£665,389,588Value from the linked contract
Official source
Open the official Find a Tender notice for NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
- This figure comes from the linked contract record. Overall totals continue to use the separately published award value.
View record references
Source
Find a Tender
Award or lot reference
ocds-h6vhtk-051c98 / 3
Transitional Drugs 7
Buyer: Velindre University NHS Trust

Vifor Pharma UK Limited

Published records by year

Buyer relationships by value counted

Published awards

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Transitional Drugs 7

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS South of England Branded Medicines - Tranche A - September 2023

NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A)

NHS England Framework Agreement - London - Tranche A

NHS England Framework Agreement: Midlands and East (Tranche A)

Proprietary Drugs

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

Intravenous (IV) Iron

NP49425 Generic and Biosimilar Transition Medicines

Denosumab (Osteoporosis) and Ferric Carboxymaltose